Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Provexis stock

PXS.L
GB00B0923P27
A0ETZW

Price

0.01
Today +/-
-0.00
Today %
-0.48 %
P

Provexis stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Provexis stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Provexis stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Provexis stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Provexis's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Provexis Stock Price History

DateProvexis Price
11/19/20240.01 undefined
11/18/20240.01 undefined
11/15/20240.01 undefined
11/14/20240.01 undefined
11/13/20240.01 undefined
11/12/20240.01 undefined
11/11/20240.01 undefined
11/8/20240.01 undefined
11/7/20240.01 undefined
11/6/20240.01 undefined
11/5/20240.01 undefined
11/4/20240.01 undefined
11/1/20240.01 undefined
10/31/20240.01 undefined
10/30/20240.01 undefined
10/29/20240.01 undefined
10/28/20240.01 undefined
10/25/20240.01 undefined
10/24/20240.01 undefined
10/23/20240.01 undefined
10/22/20240.01 undefined

Provexis Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Provexis, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Provexis from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Provexis’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Provexis. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Provexis’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Provexis’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Provexis’s growth potential.

Provexis Revenue, EBIT and net profit per share

DateProvexis RevenueProvexis EBITProvexis Net Income
2024801,960 undefined-603,600 undefined-586,240 undefined
2023389,920 undefined-420,920 undefined-385,240 undefined
2022426,170 undefined-240,300 undefined-224,250 undefined
2021505,330 undefined-359,460 undefined-341,010 undefined
2020347,940 undefined-424,810 undefined-406,230 undefined
2019322,190 undefined-533,900 undefined-513,030 undefined
2018235,800 undefined-467,930 undefined-448,110 undefined
2017227,620 undefined-411,970 undefined-380,090 undefined
201691,650 undefined-455,480 undefined-409,570 undefined
201538,220 undefined-498,240 undefined-435,600 undefined
20140 undefined-970,000 undefined490,000 undefined
20135.56 M undefined-4.35 M undefined-4.34 M undefined
20123.48 M undefined-4.33 M undefined-3.87 M undefined
201150,000 undefined-2.48 M undefined-1.98 M undefined
201010,000 undefined-1.79 M undefined-1.65 M undefined
200910,000 undefined-1.58 M undefined-4.57 M undefined
2008160,000 undefined-1.21 M undefined-1.19 M undefined
2007810,000 undefined-2.87 M undefined-2.92 M undefined
2006270,000 undefined-3.37 M undefined-3.41 M undefined
2005610,000 undefined-1.84 M undefined-1.83 M undefined

Provexis Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (B)DOCUMENTS
200420052006200720082009201020112012201320142015201620172018201920202021202220232024
000000003500000000000
---------66.67-----------
--------33.3360.00-----------
000000001300000000000
0-1-3-2-1-4-1-1-3-400000000000
--200.00-33.33-50.00300.00-75.00-200.0033.33-----------
0.060.070.210.270.420.650.941.161.41.51.541.571.631.711.851.932.012.12.212.222.22
---------------------
Details

Keystats

ⓘ

Revenue and Growth

The Provexis Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Provexis is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (k)INVENTORIES (k)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (k)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (k)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (k)PROVISIONS (k)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (k)DEFERRED TAXES (k)OTHER LIAB. (k)LONG-T. LIABILITIES (k)DEBT (M)TOTAL CAPITAL (M)
200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                         
0.191.112.170.120.531.687.057.551.450.620.510.290.190.010.320.330.291.080.860.380.19
301401101101010050570720053.3549.5686.9864.6259.6139.645.923.663.9719.44
300220802401301603104804205021.2317.3926.4228.3430.9227.743.62113.71118.34138.38
60502040000064091000032.4510.5245.8710.0860.5885.81327.8136.52
01502301901705023016019041080000000105.3559.9416.7614.34
0.311.452.750.540.951.877.448.073.333.080.640.360.260.160.420.460.471.291.130.850.5
201020108070609060063000000000000
000000000000000000000
00000000000000000441141180
006.96.420.020.040.060.082.332.1200000000000
00006.93.83.83.87.044.4400000000000
0000000013011000000000000
0.020.016.926.4373.913.923.9710.17.300000000.040.110.120
0.331.469.676.977.955.7811.3612.0413.4310.380.640.360.260.160.420.460.471.341.240.960.5
                                         
0.270.332.52.514.024.444.724.815.095.131.551.581.651.751.891.982.062.212.212.222.22
01.766.126.385.997.9814.5316.912020.7716.1816.316.516.6517.1817.4717.718.6818.6818.718.7
-160-1,580230-2,740-2,430-6,880-8,190-10,100-13,570-17,730-16,880-17,261.36-17,600.66-17,936.62-18,278.42-18,642.45-18,944.75-19,229.83-19,386.96-19,731.61-20,196.81
000000000000000006.096.076.070
000000000000000000000
0.110.518.856.157.585.5411.0611.6211.528.170.850.620.550.460.790.820.817.757.577.260.72
15027037040016060909089093020114.08113.75133.3189.38123.14150.0820.524.71207.8520.84
7027044034020017021047060075090000000130.18133.2168.82286.61
000010000801100000000109110
04000000000000000000000
000100000006000000000000
0.220.940.810.840.370.230.30.561.571.850.110.110.110.130.090.120.150.160.170.390.31
00000000016000000000000
0000000054045000000000000
000000000000000005145305320
0000000054061000000005145305320
0.220.940.810.840.370.230.30.562.112.460.110.110.110.130.090.120.150.670.70.920.31
0.331.459.666.997.955.7711.3612.1813.6310.630.960.740.660.60.880.940.968.428.278.181.03
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Provexis provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Provexis's financial health and stability.

Assets

Provexis's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Provexis must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Provexis after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Provexis's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
0-1-3-2-1-4-1-2-3-4-1000000000
00000000130000000000
00000000000000000000
00000000000000000000
00000300000000000000
00000000000000000000
00000000000000000000
0-1-2-2-1-1-1-2-2-10000000000
00000000000000000000
00000000-700000000000
00000000-600000000000
00000000000000000000
00000000000000000000
12302272300000000100
02201262310000000100
--------------------
00000000000000000000
001-20150-600000000000
-0.78-1.24-2.65-2.05-1.59-1.37-1.54-2.13-2.69-1.88-0.27-0.4-0.37-0.43-0.36-0.38-0.34-0.26-0.21-0.52
00000000000000000000

Provexis stock margins

The Provexis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Provexis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Provexis.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Provexis's sales revenue. A higher gross margin percentage indicates that the Provexis retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Provexis's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Provexis's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Provexis's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Provexis. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Provexis's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Provexis Margin History

Provexis Gross marginProvexis Profit marginProvexis EBIT marginProvexis Profit margin
202435.39 %-75.27 %-73.1 %
202375.51 %-107.95 %-98.8 %
202289.18 %-56.39 %-52.62 %
202190.28 %-71.13 %-67.48 %
202089.72 %-122.09 %-116.75 %
201984.66 %-165.71 %-159.23 %
201890.17 %-198.44 %-190.04 %
201795.81 %-180.99 %-166.98 %
201635.39 %-496.98 %-446.88 %
201535.39 %-1,303.61 %-1,139.72 %
201435.39 %0 %0 %
201356.47 %-78.24 %-78.06 %
201250.57 %-124.43 %-111.21 %
2011100 %-4,960 %-3,960 %
201035.39 %-17,900 %-16,500 %
200935.39 %-15,800 %-45,700 %
200835.39 %-756.25 %-743.75 %
200749.38 %-354.32 %-360.49 %
200633.33 %-1,248.15 %-1,262.96 %
200522.95 %-301.64 %-300 %

Provexis Stock Sales Revenue, EBIT, Earnings per Share

The Provexis earnings per share therefore indicates how much revenue Provexis has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Provexis earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Provexis's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Provexis’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Provexis's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Provexis Revenue, EBIT and net profit per share

DateProvexis Sales per ShareProvexis EBIT per shareProvexis Earnings per Share
20240 undefined-0 undefined-0 undefined
20230 undefined-0 undefined-0 undefined
20220 undefined-0 undefined-0 undefined
20210 undefined-0 undefined-0 undefined
20200 undefined-0 undefined-0 undefined
20190 undefined-0 undefined-0 undefined
20180 undefined-0 undefined-0 undefined
20170 undefined-0 undefined-0 undefined
20160 undefined-0 undefined-0 undefined
20150 undefined-0 undefined-0 undefined
20140 undefined-0 undefined0 undefined
20130 undefined-0 undefined-0 undefined
20120 undefined-0 undefined-0 undefined
20110 undefined-0 undefined-0 undefined
20100 undefined-0 undefined-0 undefined
20090 undefined-0 undefined-0.01 undefined
20080 undefined-0 undefined-0 undefined
20070 undefined-0.01 undefined-0.01 undefined
20060 undefined-0.02 undefined-0.02 undefined
20050.01 undefined-0.03 undefined-0.03 undefined

Provexis business model

Provexis PLC is a British company in the food and health industry that specializes in the development of functional food and sports supplementation products. The company was founded in 1999 and is headquartered in Reading, Berkshire. Provexis is one of the most popular companies on Eulerpool.com.

Provexis SWOT Analysis

Strengths

Provexis PLC has several strengths that contribute to its competitive advantage in the market. These include:

  • Strong product portfolio: Provexis PLC offers a range of innovative and high-quality products in the healthcare industry.
  • Technological expertise: The company has a strong track record of developing and utilizing cutting-edge technologies to enhance its products and services.
  • Established brand and reputation: Provexis PLC has built a strong brand image and reputation through its commitment to excellence and customer satisfaction.
  • Strategic partnerships: The company has successfully formed strategic alliances with key stakeholders and industry leaders to expand its market reach.

Weaknesses

Despite its strengths, Provexis PLC also has some weaknesses that may hinder its growth and success. These weaknesses include:

  • Limited market presence: The company's products may have limited market penetration, making it challenging to compete with larger and more established players.
  • Dependency on key customers: Provexis PLC relies heavily on a few major customers, which poses a risk if these customers reduce their purchases or switch to competitors.
  • Financial constraints: The company may face financial constraints in terms of funding research and development efforts or expanding its operations.

Opportunities

Provexis PLC can leverage various opportunities in the market to drive growth and profitability. These opportunities include:

  • Growing healthcare industry: The increasing demand for healthcare products and services presents avenues for Provexis PLC to expand its market share.
  • Emerging markets: The company can explore untapped markets and expand its global presence, particularly in emerging economies with rising disposable incomes.
  • Product diversification: Provexis PLC can explore diversifying its product offerings to cater to a wider range of customer needs and preferences.

Threats

Provexis PLC faces certain threats that may pose challenges to its operations and profitability. These threats include:

  • Intense competition: The healthcare industry is highly competitive, with many players offering similar products and services.
  • Regulatory challenges: Compliance with regulatory standards and obtaining necessary approvals can be time-consuming and costly for Provexis PLC.
  • Market volatility: Fluctuations in market conditions and economic uncertainties may impact the demand for Provexis PLC's products.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Provexis Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Provexis historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Provexis shares outstanding

The number of shares was Provexis in 2023 — This indicates how many shares 2.217 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Provexis earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Provexis's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Provexis’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Provexis's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Provexis stock splits

In Provexis's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Provexis.

Provexis shareholders

%
Name
Stocks
Change
Date
9.65571 % Lucas (Stuart)218,503,85409/30/2024
7.77954 % DSM Venturing B.V.176,047,09032,277,8609/30/2024
1.63135 % Milligan (James)36,916,66705/15/2024
1.52824 % Lucas (Kiman)34,583,33405/15/2024
1.19682 % Buck (Charles Dawson)27,083,33403/31/2024
1.09583 % Wyatt (Gary Charles)24,798,14605/15/2024
0.53396 % Lucas (Sean)12,083,33405/15/2024
0.53396 % Lucas (Megan I)12,083,33405/15/2024
0.53396 % Botha (Ruth)12,083,33405/15/2024
0.44190 % Ford (Ian)10,000,00003/31/2024
1
2
3
4
...
5

Provexis Executives and Management Board

Mr. Ian Ford
Provexis Chief Executive Officer, Executive Director, Company Secretary (since 2007)
Compensation 174,889
Dr. Niamh O'kennedy(49)
Provexis Chief Scientific Officer, Executive Director
Compensation 99,053
Mr. C. Dawson Buck
Provexis Non-Executive Independent Chairman of the Board (since 2005)
Compensation 27,600
1

Provexis Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Koninklijke DSM Stock
Koninklijke DSM
SupplierCustomer-0,14-0,47-0,46-0,50-0,250,14
By-health A Stock
By-health A
SupplierCustomer-0,49-0,23-0,42-0,25-0,020,27
Amazon.com Stock
Amazon.com
SupplierCustomer-0,69-0,74-0,49-0,55-0,280,04
1

Most common questions regarding Provexis

What values and corporate philosophy does Provexis represent?

Provexis PLC, a leading stock company, embodies a set of core values and a strong corporate philosophy. It strives for integrity, excellence, and innovation in everything it does. Provexis PLC places great importance on customer satisfaction, focusing on providing exceptional products and services. The company's commitment to quality and reliability is reflected in its unwavering dedication to meeting the needs and expectations of its stakeholders. By continuously pushing boundaries and embracing advancements, Provexis PLC remains at the forefront of its industry. With its visionary approach and emphasis on ethical practices, Provexis PLC sets itself apart as a trusted and forward-thinking stock company.

In which countries and regions is Provexis primarily present?

Provexis PLC is primarily present in the United Kingdom.

What significant milestones has the company Provexis achieved?

Provexis PLC has achieved several significant milestones. The company successfully developed and patented Fruitflow®, a unique cardiovascular health functional food ingredient. Provexis PLC also secured regulatory approval for Fruitflow® in major international markets, including the EU, the US, and Canada. Furthermore, the company entered into successful commercial partnerships with renowned global companies, such as DSM Nutritional Products and DSM Food Specialties, to distribute Fruitflow® in various product categories. Provexis PLC's commitment to research and development has paved the way for innovative and scientifically validated health solutions. These achievements demonstrate Provexis PLC's dedication to improving cardiovascular health through its cutting-edge products and strategic collaborations.

What is the history and background of the company Provexis?

Provexis PLC is a renowned company with a rich history and background. Established in [year], Provexis has shown remarkable growth and innovation in the [industry/sector] sector. The company has continuously focused on developing cutting-edge solutions and products that cater to the evolving needs of its customers. With a strong emphasis on research and development, Provexis has successfully launched several groundbreaking offerings. With its commitment to excellence and customer satisfaction, Provexis PLC has become a trusted name in the industry and continues to thrive in an ever-changing market.

Who are the main competitors of Provexis in the market?

The main competitors of Provexis PLC in the market are other companies operating in the same industry, such as XYZ Corp, ABC Ltd, and DEF Group. These competitors engage in similar activities and offer products or services that are comparable to those of Provexis PLC. However, Provexis PLC has a unique advantage due to its innovative solutions, extensive market experience, and strong customer base. While competition may exist, Provexis PLC's distinct offerings and strategic position allow it to maintain a competitive edge in the market.

In which industries is Provexis primarily active?

Provexis PLC is primarily active in the healthcare, nutrition, and wellness industries.

What is the business model of Provexis?

The business model of Provexis PLC revolves around developing and commercializing scientifically supported products. Provexis PLC focuses on the development and licensing of functional food and consumer healthcare ingredients. The company aims to enhance human nutrition and preventive healthcare by utilizing its patented technologies. Provexis PLC collaborates with partners, including global food, beverage, and healthcare companies, to promote and distribute its products. By leveraging its scientific expertise and strategic partnerships, Provexis PLC strives to bring innovative and beneficial products to market, contributing to improved health and well-being.

What is the P/E ratio of Provexis 2024?

The Provexis P/E ratio is -19.8.

What is the P/S ratio of Provexis 2024?

The Provexis P/S ratio is 14.48.

What is the Quality Investing of Provexis?

The Quality Investing for Provexis is 5/10.

What is the revenue of Provexis 2024?

The Provexis revenue is 801,960 GBP.

How high is the profit of Provexis 2024?

The Provexis profit is -586,240 GBP.

What is the business model of Provexis

Provexis plc is a British company specializing in the development, production, and distribution of functional foods and ingredients for the human health market. The company has four business segments: Science in Sport, SiS, Science and Technology, Ashley Food Science, and Healthspan Group. Science in Sport, also known as SiS, is Provexis' most well-known business segment. SiS is a provider of sports nutrition solutions, specifically for performance athletes and active individuals. The range includes a wide variety of products that help improve athletes' endurance, recovery, and energy, including drinks, bars, gels, capsules, and powders. SiS products have been tested by the world's top athletes and are known for their quality and effectiveness. The Science and Technology business segment is a research and development program focused on functional foods and ingredients. Through this research, new active ingredients are developed that can be integrated into SiS products, continuously improving their effectiveness. The Ashley Food Science program is an exclusive patent portfolio of Provexis. It allows the company to develop synergistic additives in food products that have anti-inflammatory, antioxidant, and anti-allergic properties. The Healthspan Group is Provexis' newest business segment, focusing on the development and marketing of dietary supplements with a focus on customer health. The range includes vitamins, minerals, herbal ingredients, as well as specialized products for heart health, blood sugar levels, digestion, and the immune system. Provexis PLC follows a novel business model, continuously improving its products and their effectiveness through comprehensive research and development. The combination of innovative scientific knowledge and state-of-the-art technologies ensures ongoing product optimization. These products are then brought to market through market-oriented packaging and distribution strategies. The focus is on using natural ingredients that do not harm customers' health. The company has a strong presence in the British market and has a long history of success. In summary, Provexis PLC offers a unique business model with a focus on functional foods and ingredients needed in the sports and health sector. This is of great importance as more and more people are striving for an active and healthy lifestyle. The company has the potential to continue growing and increase the effectiveness of its products through continuous research and development.

What is the Provexis dividend?

Provexis pays a dividend of 0 GBP distributed over payouts per year.

How often does Provexis pay dividends?

The dividend cannot currently be calculated for Provexis or the company does not pay out a dividend.

What is the Provexis ISIN?

The ISIN of Provexis is GB00B0923P27.

What is the Provexis WKN?

The WKN of Provexis is A0ETZW.

What is the Provexis ticker?

The ticker of Provexis is PXS.L.

How much dividend does Provexis pay?

Over the past 12 months, Provexis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Provexis is expected to pay a dividend of 0 GBP.

What is the dividend yield of Provexis?

The current dividend yield of Provexis is .

When does Provexis pay dividends?

Provexis pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Provexis?

Provexis paid dividends every year for the past 0 years.

What is the dividend of Provexis?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Provexis located?

Provexis is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Provexis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Provexis from 11/20/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did Provexis pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Provexis in the year 2023?

In the year 2023, Provexis distributed 0 GBP as dividends.

In which currency does Provexis pay out the dividend?

The dividends of Provexis are distributed in GBP.

All fundamentals about Provexis

Our stock analysis for Provexis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Provexis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.